Morgan Stanley Maintains Underweight on Lazard, Lowers Price Target to $52

Benzinga Newsdesk www.benzinga.com Negative 89.3%

Neg 89.3% Neu 0% Pos 0%

Morgan Stanley analyst Ryan Kenny maintains Lazard (NYSE:LAZ) with a Underweight and lowers the price target from $59 to $52.